Paid Clinical Trials Nashua
Discover 144 paid clinical trials in Nashua, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Engagement EnhancementEnhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Sponsor:
Dartmouth-Hitchcock Medical Center
Location:
Code:
NCT06898593
Conditions
Anxiety Disorders
Depression Disorders
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Collaborative care model with clinical decision support system
Collaborative care model
Observational StudyReal-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Sponsor:
Neurocrine Biosciences
Location:
Code:
NCT03062033
Conditions
Tardive Dyskinesia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
AtogepantA Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor:
AbbVie
Location:
Code:
NCT06810505
Conditions
Chronic Migraine
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
Atogepant
Placebo for Atogepant
VNS TherapyA Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Sponsor:
LivaNova
Location:
Code:
NCT03887715
Conditions
Treatment Resistant Depression
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Vagus Nerve Stimulation (VNS)
Locator Guided vs. Wire LocalizedBreast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer
Sponsor:
CairnSurgical, Inc.
Location:
Code:
NCT04397185
Conditions
Breast Cancer Female
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Breast Cancer Locator (BCL) guided partial mastectomy
Wire Localized (WL) partial mastectomy
Interested in new trials?
Get alerts for new trials in your area by subscribing now
UbrogepantStudy to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor:
AbbVie
Location:
Code:
NCT05125302
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Ubrogepant
Placebo-Matching Ubrogepant
ChemotherapyThe PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT06115499
Conditions
Pancreatic Acinar Cell Carcinoma
Pancreatic Adenocarcinoma
Pancreatic Adenosquamous Carcinoma
Pancreatic Carcinoma
Pancreatic Ductal Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nab paclitaxel
Gemcitabine
Cisplatin
Magnetic Resonance Imaging
Computed Tomography
Armour Thyroid vs. T4A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Sponsor:
AbbVie
Location:
Code:
NCT06345339
Conditions
Hypothyroidism
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Armour Thyroid
Levothyroxine
Cancer MoonshotNational Cancer Institute "Cancer Moonshot Biobank"
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04314401
Conditions
Acute Myeloid Leukemia
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
Clinical Stage IV Gastric Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 13+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Magnetic Resonance Imaging
Medical Chart Review
Paracentesis
Observational StudyStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Sponsor:
Dana-Farber Cancer Institute
Location:
Code:
NCT02269592
Conditions
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Chronic Lymphocytic Leukemia (CLL)
Myelodysplastic Syndromes
Hematological Malignancies
B-cell Malignancy, Low-grade
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted